About TTS Pharma
TTS Pharma is a company based in Liverpool (United Kingdom) founded in 2012. It operates as a B2B2C and White Labeling. TTS Pharma has raised $13.94 million across 2 funding rounds from investors including The North West Fund. The company has 6 employees as of December 31, 2020. TTS Pharma offers products and services including CBD for Cosmetics, CBD for Food Supplements, Food and Beverages, and White Labelling. TTS Pharma operates in a competitive market with competitors including Ergomed and Celadon Pharmaceuticals, among others.
- Headquarter Liverpool, United Kingdom
- Employees 6 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Tts Pharma Limited
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$13.94 M (USD)
in 2 rounds
-
Latest Funding Round
$13.06 M (USD), Series B
May 23, 2019
- Investors
-
Employee Count
6
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of TTS Pharma
TTS Pharma offers a comprehensive portfolio of products and services, including CBD for Cosmetics, CBD for Food Supplements, Food and Beverages, and White Labelling.
Cannabinoid products are developed for cosmetic industry applications.
Cannabinoid supplements are produced for dietary health benefits.
Cannabinoid ingredients are supplied for food and beverages.
White labelling services are offered for cannabinoid products.
People of TTS Pharma
Unlock access to complete
Unlock access to complete
Funding Insights of TTS Pharma
TTS Pharma has successfully raised a total of $13.94M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $13.06 million completed in May 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $13.1M
-
First Round
First Round
(01 Dec 2012)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2019 | Amount | Series B - TTS Pharma | Valuation |
investors |
|
| Dec, 2012 | Amount | Seed - TTS Pharma | Valuation |
investors |
Investors in TTS Pharma
TTS Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include The North West Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt firm
|
Founded Year | Domain | Location |
Investments & Acquisitions by TTS Pharma
Financial Statements - TTS Pharma
Tts Pharma Comparisons
Competitors of TTS Pharma
TTS Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ergomed and Celadon Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Full-service CRO operations are focused on oncology and complex trials.
|
|
| domain | founded_year | HQ Location |
Provider of cannabis trial services
|
Latest news on Tts Pharma
Frequently Asked Questions about TTS Pharma
TTS Pharma was founded in 2012.
TTS Pharma is headquartered in Liverpool, United Kingdom.
TTS Pharma is a funded company, having raised a total of $13.94M across 2 funding rounds to date. The company's 1st funding round was a Seed of $881.82K, raised on Dec 01, 2012.
As of Dec 31, 2020, the latest employee count at TTS Pharma is 6.
TTS Pharma Limited, based in the UK, is focused on the production of high-quality, safe Cannabinoid products for the ethical cannabis market. Operations are conducted within the legal frameworks of the UK and Europe, adhering to regulations set by the Home Office, Food Standards Agency, and Trading Standards. Products are developed for sectors including food, cosmetics, and nutraceuticals, with an ambition to become a leading European supplier. Advanced extraction technologies are utilized to purify components for use as Active Pharmaceutical Ingredients (API). Emphasis is placed on supply chain transparency to ensure consumer and patient trust.
TTS Pharma's top competitors include Celadon Pharmaceuticals and Ergomed.
TTS Pharma offers CBD for Cosmetics, CBD for Food Supplements, Food and Beverages, and White Labelling.
TTS Pharma has 1 investor. Key investors include The North West Fund.